Changes of rat plasma total low molecular weight antioxidant level after tabun exposure and consequent treatment by acetylcholinesterase reactivators

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 26, Issue 1, 2011, Pages 93-97

  Pohanka, Miroslav ^a,b   Karasova, Jana Zdarova ^b   Musilek, Kamil ^b   Kuca, Kamil ^a,b   Jung, Young Sik ^c   Kassa, Jiri ^b  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

^c Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Acetylcholinesterase; antioxidant; cholinergic antiinflammatory pathway; nerve agent; oxime; reactivator; tabun

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; ANTIOXIDANT; ATROPINE; CHOLINESTERASE; CHOLINESTERASE REACTIVATOR; K 203; KR 22836; LOW MOLECULAR WEIGHT ANTIOXIDANT; OBIDOXIME; TABUN; TRIMEDOXIME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CHOLINESTERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG SYNTHESIS; ENZYME ACTIVITY; INTOXICATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ACETYLCHOLINESTERASE; ANIMALS; ANTIDOTES; ANTIOXIDANTS; ATROPINE; CHOLINESTERASE INHIBITORS; CHOLINESTERASE REACTIVATORS; MALE; MOLECULAR WEIGHT; OXIDATIVE STRESS; OXIMES; PHOSPHORIC ACID ESTERS; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 79851500093     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756361003733613     Document Type: Article

References (35)

1. Soreq H, Seidman S. Acetylcholinesterase-new role for an old actor. Natur Rev 2001;2: 294-302.
2. Pavlov VA, Wang H, Czura CJ, SG Friedman, Tracey KJ. Te cholinergic anti-infammatory pathway: a missing link in neuroimmunomodulation. Mol Med 2003;9: 125-134. (Pubitemid 37310949)
3. Rosas-Ballina M, Tracey KJ. Cholinergic control of infammation. J Intern Med 2005;6: 663-679.
4. Van Der Zanden EP, Boeckxstaens GE, de Jonge WJ. Te vagus nerve as a modulator of intestinal infammation. Neurogastroenterol Motil 2009;21:6-17.
5. Bajgar J. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 2004;38:151-216.
6. Pohanka M, Musilek K, Kuca K. Progress of biosensors based on cholinesterase inhibition. Curr Med Chem 2009;16:1790-1798.
7. Organ G, Orhan I, Subutay-Oztekin N, Ak F, Sener B. Contemporary anticholinesterase pharmaceuticals of natural origin and their synthetic analogues for the treatment of Alzheimer's disease. Recent Pat CNS Drug Discov 2009;4:43-51.
8. France JL, Posser T, Mattos JJ, Trevisan R, Brocardo RS, Rodriques AL, Leal RB, Farina M, Marques MR, Bainy AC, Dafre AL. Zinc reverses malathion-induced impairment in antioxidant defenses. Toxicol Lett 2009;187:137-143.
9. Buyukguzel E. Evidence of oxidative and antioxidative responses by Galleria mellanella larvae to malathion. J Econ Entomol 2009;102:152-159.
10. Pohanka M, Zdarova-Karasova J, Musilek K, Kuca K, Kassa J. Efect of fve acetylcholinesterase reactivators on tabun-intoxicated rats: induction of oxidative stress versus reactivation efcacy. J Appl Toxicol 2009;29:483-488.
11. Musilek K, Holas O, Jun D, Dohnal V, Gunn-Moore F, Opletalova V, Dolezal M, Kuca K. Monooxime reactivators of acetylcholinesterase with (E)-but-2-ene linker: preparation and reactivation of tabun-and paraoxon-inhibited acetylcholinesterase. Bioorg Med Chem 2007;15:6733-6741. (Pubitemid 47385242)
12. Ellman GL, Courtney DK, Andreas V, Reastherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95.
13. Pohanka M, Stetina R. Shift of oxidants and antioxidants levels in rats as a reaction to exposure to sulfur mustard. J Appl Toxicol 2009;29:643-647.
14. Supalkova V, Huska D, Diopan V, Hanustlak P, Zika O, Stejskal K, Baloun J, Pikula J, Havel L, Zehnalek J, Adam V, Trnkova L, Beklova M, Kizek R. Electroanalysis of plant thiols. Sensors 2007;7:932-952.
15. Chevion S, Roberts MA, Chevion M. Te use of cyclic voltammetry for the evaluation of antioxidant capacity. Free Radic Biol Med 2000;28:860-870. (Pubitemid 30235158)
16. Pohanka M, Jun D, Kuca K. Improvement of acetylcholinesterase-based assay for organophosphates in way of identifcation by reactivators. Talanta 2008;77:451-454.
17. Kovarik Z, Calic M, Sinko G, Bosak A. Structure-activity approach in the reactivation of tabun-phosphorylated human acetylcholinesterase with bispyridinium para-aldoximes. Arh Hig Rada Toksikol 2007;58:201-209. (Pubitemid 46918165)
18. Sinko G, Calic M, Bosak A, Kovarik Z. Limitation of the Ellman method: cholinesterase activity measurement in the presence of oximes. Anal Biochem 2007;370:223-227. (Pubitemid 47484313)
19. Pohanka M, Novotny L, Misik J, Kuca K, Zdarova-Krasova J, Hrabinova M. Evaluation of cholinesterase activites during in vivo intoxication using an electrochemical sensor strip-correlation with intoxication symptoms. Sensors 2009;9:3627-3634.
20. Franco R, Schoneveld OJ, Pappa A, Pnaviotidis MI. Te central role of glutathione in the pathophysiology of human diseases. Arch Physiol Biochem 2007;113:234-258.
21. Markart P, Luboeinski TG, Korfei M, Schmidt R, Wygrecka M, Mahavadi P, Mayer K, Wilhelm J, Seeger W, Guenther A, Ruppert C. Alveolar oxidative stress is associated with elevated levels of nonenzymatic low-molecular weight antioxidants in patients with diferent forms of chronic fbrosing interstitial lung diseases. Antioxid Redox Signal 2009;11:227-240.
22. Mares J, Palikova M, Kopp R, Navratil S, Pikula J. Changes in the nutritional parameters of muscles of the common carp (Cyprinus carpio) and the silver carp (Hypophthalmichthys molitrix) following environmental exposure to cyanobacterial water bloom. Aquacultur Res 2009;40:148-156.
23. Skocovska B, Hilscherova K, Babica P, Adamovsky O, Bandouchova H, Horakova J, Knotkova Z, Marsalek B, Paskova V, Pikula J. Efects of cyanobacterial biomass on the Japanese quail. Toxicon 2007;49:793-803. (Pubitemid 46613891)
24. Friedman A, Kaufer D, Shemer J, Hendler I, Soreq H, Tur-Kaspa I. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nat Med 1996;2:1382-1385.
25. Tracey KJ. Physiology and immunology of the cholinergic antiinfammatory pathway. J Clin Invest 2007;117:289-296. (Pubitemid 46203953)
26. Pavlov VA, Tracey KJ. Te cholinergic anti-infammatory pathway. Brain Behav Immun 2005;19:493-499.
27. Lorke DE, Kalasz H, Petroianu GA, Tekes K. Entry of oximes into the brain: a review. Curr Med Chem 2008;15:743-753. (Pubitemid 351516790)
28. Jokanovic M, Prostran M. Pyridinium oximes as cholinesterase reactivators. Structure-activity relationship and efcacy in the treatment of poisoning with organophosphorus compounds. Curr Med Chem 2009;16:2177-2188.
29. Zimmermann M, Gardoni F, DiLuca M. Molecular rationale for the pharmacological treatment of Alzheimer's disease. Drugs Aging 2005;22:27-37. (Pubitemid 41565870)
30. Kassa J, Karasova J. A comparison of the potency of newly developed oximes (K047, K075) and currently available oximes (obidoxime, HI-6) to counteract soman-induced neurotoxicity in rats. Drug Chem Toxicol 2007;30:117-131. (Pubitemid 46633850)
31. Ozen T, Tas M. Screening and evaluation of antioxidant activity of some amido-carbonyl oxime derivatives and their radical scavenging activities. J Enzyme Inhib Med Chem 2009;24:1141-1147.
32. Milatovic D, Gupta RC, Aschner M. Anticholinesterase toxicity and oxidative stress. Te Scientifc World Journal 2006;6:295-310.
33. Chiou SY, Huang CF, Yeh SJ, Chen IR, Lin G. Stereoselective inhibition of butyrylcholinesterase by enantiomers of exo-and endo-2-norbornyl-N-n- butylcarbamates. J Enzyme Inhib Med Chem 2010;25:13-20.
34. Haq Z, Hadi H, Moin ST, Choudhary MI. Molecular dynamics simulation of Axillaridine-A: a potent natural choinesterase inhibitor. J Enzyme Inhib Med Chem 2009;24:1101-1105.
35. Suganthy N, Pandian SK, Devi KP. Cholinesterase inhibitory efects of Rhizophora lamarckii, Avicennia ofcinalis, Sesuvium portulacastrum and Suaeda monica: mangroves inhabiting an Indian coastal area (Vellar Estuary). J Enzyme Inhib Med Chem 2009;24:702-707.